Skip to content
orbyd

Dossier · OKLO · Watchlist

OKLO · Oklo Inc.

LOW Theme leader Catalyst · nuclear-uranium

Last analysed ·

Current thesis

Nuclear-for-AI-power theme MATURING and in distribution. The 5/13 Q1 made OKLO a top-10 large-cap loser; the 5/26 DOE-plutonium bounce faded as CEO+COO sold ~$27M (10b5-1, surfaced 6/3, -12%), and shares broke to ~$58 by 6/5 under the $64.99–$70.45 insider range and Goldman's $66 PT. A live $400M ATM shelf is a standing dilution overhang. Broken structure, falling knife, no clean entry.

Invalidation trigger

Avoid-thesis flips bullish on a daily reclaim of the $66–$70 shelf (above Goldman $66 PT and the insider-sale range) on expanding volume with NO fresh 424B/ATM takedown. Otherwise a weekly close below the 2026-05-18 post-Q1 low, a 424B takedown off the $400M shelf, or any new insider Form 4 within 2 weeks of June 1 confirms the breakdown.

Thesis status

Open commitment catalyst duescored if the trigger above fires How this is scored →

Current Thesis

Pre-revenue fast-reactor SMR developer (Aurora) that trades as the highest-beta expression of the nuclear-for-AI-power theme. That theme has matured into open distribution. The 2026-05-13 Q1 print drew a negative reaction (top-10 large-cap loser, week of May 11–15); the 2026-05-26 DOE Surplus Plutonium selection sparked a bounce into the low $70s that was immediately sold; on June 1 the CEO and COO/co-founder unloaded ~$27M combined at $64.99–$70.45, the Form 4s surfaced 2026-06-03 (-12%), and the stock broke to ~$58 by 6/5. It has since drifted to ~$57.49 (2026-06-13), with UBS cutting its target to $55 on 6/11. Analyst floors are now being lowered to meet the tape rather than the tape rising to meet targets a broken-structure name to trade event-by-event, not a fresh long.

Bull Case

  • DOE Surplus Plutonium Utilization Program: selected for advanced negotiations 2026-05-26 (Benzinga). First concrete federal fuel-supply tie-in; a signed definitive agreement would be a fresh re-rate trigger.
  • Vertical integration accelerating: 2026-06-08 announced acquisition of ARMEC (Oak Ridge, TN, ~40 engineers/fabricators, closed 2026-06-04), bringing high-precision machining, fabrication and fuel-manufacturing in-house to compress the design-to-deployment timeline (Businesswire 2026-06-08).
  • Bullish targets held through the weak quarter: Cantor Overweight $122 and Wedbush Outperform $110, both reiterated 2026-05-27, versus a ~$57 quote wide implied upside if structure repairs.
  • Post-Q1 dip was bought aggressively on 2026-05-20 ("Why Is Oklo Stock Surging On Wednesday", Benzinga) real demand appeared beneath the tape once before.
  • June 1 insider sales were pre-arranged under a 10b5-1 plan adopted 2025-03-31 (StockTitan/Investing.com), not opportunistic discretionary selling a partial mitigant to the distribution read.

Bear Case

  • Analyst floor keeps dropping: UBS lowered its target to $55 from $60 (Neutral) on 2026-06-11, citing capital requirements and project-execution risk (Investing.com). With price ~$57.49, the bullish dispersion (Cantor $122, Wedbush $110) no longer has price confirmation.
  • June 1 insider sales: CEO Jacob DeWitte (200,000 sh) and COO/co-founder Caroline Cochran ($13.6M), ~$27M combined at $64.99–$70.45; filings surfaced 2026-06-03 → -12% (Benzinga). Founders monetizing the DOE bounce on a zero-revenue name is the loudest signal on the chart.
  • Capital-raise machinery is live: a Form S-3 covering up to $1B and an ATM equity distribution agreement for up to $400M (Goldman, BofA, B. Riley, TD) are in force. The ARMEC deal deploys capital with no disclosed terms while the company is pre-revenue; a 424B prospectus supplement would confirm an active takedown.
  • Price broke its analyst floor and made a lower high: ~$58 on 2026-06-05 was under Goldman's $66 PT and the entire insider-sale range; the DOE bounce rolled over.
  • Down ~17% on the week and ~48% over six months as of the 2026-06-11 UBS note sustained distribution, not a single shock.
  • Wolfe Research initiated Peer Perform (neutral) on 2026-05-19 fresh coverage skewed cautious, not additive to the bull stack.
  • PT dispersion remains ~10x (low ~$14 / UBS $55 / Goldman $66 / Wedbush $110 / Cantor $122 / high ~$140) no fundamental anchor; the name trades on tape and headlines.
  • Newcleo's SPAC merger (WSJ/Benzinga 2026-05-27) adds more advanced-nuclear paper competing for the same thematic capital a late-cycle supply signal.

Setup & Price Structure

Sequence: April space-nuclear vertical (records, RSI mid-70s) → 2026-05-13 Q1 → negative reaction (top-10 large-cap loser, week of May 11–15) → 2026-05-18 sliding/critical-levels → 2026-05-20 dip-buy → 2026-05-26 DOE plutonium bounce into the low $70s → sold via the 2026-06-03 insider Form 4s (-12%) → ~$58 on 6/5 → ~$57.49 on 6/13. The structure is a lower high into the DOE news followed by a clean break of the $64.99–$70.45 insider range and Goldman's $66 PT. Price now sits just above the freshly-cut UBS $55 target, which functions as the next reference shelf analysts lowering targets toward the tape is a distribution characteristic, not accumulation. No higher-low reclaim has printed; this is a falling knife with a standing $400M ATM overhang. A fresh long requires the name to base and reclaim, not catch the drop.

Catalyst Calendar (next 30 days)

  • No company-scheduled binary inside the window. Q2 FY2026 earnings est. ~2026-08-12 (mid-August) catalyst-light until then.
  • DOE Surplus Plutonium definitive agreement: undated; negotiations advanced 2026-05-26 could land any session and is the live federal-fuel swing factor (signed terms = upgrade, lapse = thesis dent).
  • NRC Aurora COLA docket action: undated long-duration binary (2022 denial precedent) docket acceptance = upgrade, denial/delay = thesis broken.
  • 424B/ATM takedown off the live $400M shelf: undated standing risk; any filing into strength is an immediate stand-aside.
  • Follow-on insider Form 4 within the 10b5-1 window (~2026-06-15 onward): undated; any further disclosed selling confirms distribution.

What Would Change Our Mind

The bearish read flips constructive only on a daily reclaim of the $66 shelf back above Goldman's PT and the $64.99–$70.45 insider-sale range on expanding volume, with no fresh 424B/ATM takedown. Short of that, a basing structure with a confirmed higher low and a reclaim of the 20-EMA would be the first repair signal worth a probe. Conversely, a weekly close below ~$55 (the UBS target / June-low zone), a 424B prospectus supplement off the $400M shelf, or any new insider Form 4 confirms the breakdown and keeps fresh entries off the table.

Correlation Notes

OKLO carries the highest beta in the advanced-nuclear basket it leads the cohort on the way up and leads it down on rotation; it should not be averaged into on basket weakness. Co-moves with SMR peers (NuScale/SMR, NNE), uranium (CCJ, URA) and the AI-power complex (VST, CEG, GEV, TLN) when the nuclear-for-datacenter narrative is bid. As a pre-revenue, long-duration name it is acutely rate-sensitive: UBS explicitly tied its 6/11 cut to capital requirements, so rising yields and risk-off rotation hit it harder than cash-generative peers. Newcleo's 2026-05-27 SPAC adds competing nuclear paper that dilutes the thematic capital pool. The DOE plutonium and NRC docket catalysts are idiosyncratic and can decouple it from the basket in either direction on a single headline.

Notes

  • 2026-04-18: seed: Serenity/attention list
  • Pre-revenue: treat as event-driven, not fundamentals. Position sizing must anticipate 15%+ single-day moves.
  • Earnings blackout begins ~2026-05-08 (T-3 trading days before est. 2026-05-13 print).
  • Raise risk is acute: management has every reason to file ATM/S-3 after the record-week run. Any such filing = immediate exit, no debate.
  • NRC COLA path is the long-duration binary (2022 denial precedent). Docket acceptance = upgrade; denial/delay = thesis broken.
  • Beta to nuclear basket: highest. When cohort rotates out, Oklo leads the drop do not average down on basket weakness.
  • 2026-04-20 first red tape day post-rally is the early distribution tell. Fresh entry requires pullback + higher-low reclaim
  • not chase.
  • Pre-revenue: event-driven, not fundamentals. Size for 15%+ single-day moves in both directions.
  • 2026-06-03: co-founders disclosed $13.6M insider share sales (Form 4) -> -12%. Insider distribution into strength is the loudest tell on a pre-revenue name; any follow-on Form 4 = hard avoid.
  • Raise risk acute: post-bounce window is when pre-revenue issuers file ATM/S-3. Any 424B/S-3 = immediate exit/skip, no debate.
  • DOE Surplus Plutonium Utilization Program (5/26 advanced negotiations) is the live federal-fuel catalyst; signed definitive agreement = upgrade, lapse = thesis dent.
  • Analyst PT dispersion ~2x (Goldman $66 vs Cantor $122, May) = no fundamental anchor. Trade the tape, not the targets.
  • Beta to nuclear basket highest; leads the cohort drop on rotation. Never average down on basket weakness.
  • NRC Aurora COLA docket is an undated long-duration binary (2022 denial precedent).
  • Newcleo SPAC (5/27) = late-cycle supply / capital-competition signal for the nuclear theme; watch for rotation OUT of OKLO.
  • Q1 printed 2026-05-13 (negative reaction). Q2 est. ~mid-August. Catalyst-light window until DOE plutonium terms land.
  • 2026-06-01 insider sales: CEO Jacob DeWitte 200,000 sh + co-founder/COO Caroline Cochran $13.6M at $64.99-$70.45 (~$27M combined), under a 10b5-1 plan adopted 2025-03-31. Form 4s surfaced 2026-06-03 -> -12%. Any additional Form 4 within 2 weeks = hard avoid.
  • LIVE dilution machinery: Form S-3 for up to $1B + ATM equity distribution agreement for up to $400M with Goldman/BofA/B.Riley/TD already in force. A 424B prospectus supplement = active takedown = immediate skip/exit, no debate.
  • Price ~$58.09 on 2026-06-05: below the insider-sale range AND Goldman's $66 PT. Bounce made a lower high; structure rolled.
  • DOE Surplus Plutonium Utilization Program: advanced negotiations opened 2026-05-26. Signed definitive agreement = upgrade; lapse = thesis dent.
  • Analyst PT dispersion ~10x: low $14 / Goldman $66 / Wedbush $110 / Cantor $122 / high $140; consensus avg ~$83-89 (16 analysts, Buy, as of 2026-06-03). No fundamental anchor trade the tape, not the targets.
  • NRC Aurora COLA docket is an undated long-duration binary (2022 denial precedent). Docket acceptance = upgrade.
  • Newcleo SPAC merger (2026-05-27) = late-cycle nuclear supply / capital-competition signal; watch for rotation OUT of the group.
  • Q2 print est. ~2026-08-14; earnings blackout begins ~T-3 trading days prior.
  • Fresh entry requires a $66-$70 shelf reclaim on volume with NO new dilution filing not a chase and not a knife-catch.

Related · shared themes

CCJ

Cameco Corporation

Q1 confirmed both legs bullish (adj EBITDA C$509M, Westinghouse C$122M, FY guide held), but price won't follow: the early-June bounce stalled at $114 and reversed -6.6% to $106.44 on 2026-06-05 a lower high rejected at the ~$115 — reclaim zone while spot firmed near $86.5/lb. Theme MATURING, structure broken; probe-only until a real higher-low reclaim of $115 on volume.

LOW

NNE

Nano Nuclear Energy Inc.

May catalyst cluster (NRC acceptance 5/20, SMCI MOU, $13M STS buy) is spent and the nuclear-powers-AI theme cooled ACCELERATING→MATURING on 6/05; price lost the ~$24 post-NRC base into the low $20s (intraday $22.76) with a live $400M ATM armed. Faded leg, not a fresh entry re-entry only on a held higher low above ~$22–24 with the theme re-accelerating.

LOW

SMR

NuScale Power Corporation

Undated South Korea $200B-package binary (NuScale Tennessee/Uljin SMR; Doosan + Samsung C&T) is the only live leg, but the June 1–2 pop to ~$14 fully round-tripped and broke to a $10.50 close (6/5) on 45%-above-avg volume, pressing the $8.85 52-wk low. Fundamentals broken (Q1 rev $0.565M, −96%); Citi $7 / Goldman $9 at/below spot. Sell-the-rip into lows pass on the chase, watchlist a confirmed deal + base.

LOW

UUUU

Energy Fuels Inc.

Rare-earth ex-China leg drove a June 2 +12% spike to $19.75 on the first US mine-to-oxide Tb/Dy oxide, but it blew off: -13.5% June 5 to $15.03, a weekly close back under the $16 mid-May shelf. Fundamental narrative (ASM vote June 22, Q4-2026 commercial heavy-REE) intact; price structure broken. Failed-spike reversal no clean setup, probe only on a base reclaim above ~$17.

LOW